Concepedia

Deborah H. Brotherton

DH

15

Publications

1.9K

Citations

14

H-Index

1992

Active since

Affiliations

Nerviano Medical Sciences(Current)

University of Warwick

University of Cambridge

DuPont (United States)

University of Leicester

Deborah H. Brotherton is an author at Nerviano Medical Sciences specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1992–2025

15

Publications

15

RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain

S. Picaud, Christopher Wells, I. Felletar et al. · Proceedings of the National Academy of Sciences · 2013 · 475 citations · Full text

Identification of Mcm2 Phosphorylation Sites by S-phase-regulating Kinases

Alessia Montagnoli, Barbara Valsasina, Deborah H. Brotherton et al. · Journal of Biological Chemistry · 2006 · 222 citations · Full text

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity

Alessia Montagnoli, Barbara Valsasina, Valter Croci et al. · Nature Chemical Biology · 2008 · 213 citations · Full text

, , +7

Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d

Deborah H. Brotherton, V. Dhanaraj, Scott Wick et al. · Nature · 1998 · 208 citations

, , +10

Cdc7 Inhibition Reveals a p53-Dependent Replication Checkpoint That Is Defective in Cancer Cells

Alessia Montagnoli, Pierluigi Tenca, Francesco Sola et al. · Cancer Research · 2004 · 137 citations · Full text

Rows per page

1–5 of 15